Xencor (XNCR) Return on Capital Employed Growth (5y) (2019 - 2026)
Xencor (XNCR) Return on Capital Employed Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Xencor | 1.49 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,496.00 |
| Dec 31, 2025 | -900.00 |
| Sep 30, 2025 | -111.00 |
| Jun 30, 2025 | -270.00 |
| Mar 31, 2025 | -773.00 |
| Dec 31, 2024 | -2,234.00 |
| Sep 30, 2024 | -2,697.00 |
| Jun 30, 2024 | -2,572.00 |
| Mar 31, 2024 | -1,992.00 |
| Dec 31, 2023 | -154.00 |
| Sep 30, 2023 | -1,048.00 |
| Jun 30, 2023 | -793.00 |
| Mar 31, 2023 | -891.00 |
| Dec 31, 2022 | 279.00 |
| Sep 30, 2022 | 2,593.00 |
| Jun 30, 2022 | 2,051.00 |
| Mar 31, 2022 | 683.00 |
| Dec 31, 2021 | -210.00 |
| Sep 30, 2021 | -2,783.00 |
| Jun 30, 2021 | -3,200.00 |